ArticleHealth economics review2015

The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia.

Sherif A Nasef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.